BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23116837)

  • 1. Advanced anal squamous cell carcinoma -- radiotherapy or surgery?
    Smigielski J; Rychter A; Fijuth J; Brocki M
    Chirurgia (Bucur); 2012; 107(5):626-30. PubMed ID: 23116837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemotherapy for anal carcinoma - effectivity and late toxicity.
    Mai SK; Grieger J; Lachmann R; Bohrer M; Tiefenbacher U; Wenz F
    Onkologie; 2002 Feb; 25(1):55-9. PubMed ID: 11893884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
    Klas JV; Rothenberger DA; Wong WD; Madoff RD
    Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominoperineal resection for squamous cell anal carcinoma: survival and risk factors for recurrence.
    Lefèvre JH; Corte H; Tiret E; Boccara D; Chaouat M; Touboul E; Svrcek M; Lefrancois M; Shields C; Parc Y
    Ann Surg Oncol; 2012 Dec; 19(13):4186-92. PubMed ID: 22825769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base.
    Geltzeiler CB; Nabavizadeh N; Kim J; Lu KC; Billingsley KG; Thomas CR; Herzig DO; Tsikitis VL
    Ann Surg Oncol; 2014 Oct; 21(11):3616-20. PubMed ID: 24943237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the anus treated with primary radiation therapy and chemotherapy.
    Johnson D; Lipsett J; Leong L; Wagman LD; Terz JJ
    Surg Gynecol Obstet; 1993 Oct; 177(4):329-34. PubMed ID: 8211574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
    Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
    Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of carcinoma anal canal with combination chemotherapy and concurrent radiotherapy.
    Mishra RC; Senapati S; Sai PL
    J Indian Med Assoc; 1996 Feb; 94(2):53-4, 57. PubMed ID: 8810177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of anal cancer].
    Witzigmann H; Sagasser J; Meyer FM; Witte J
    Chirurg; 1994 Apr; 65(4):344-51. PubMed ID: 8020355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.